A detailed history of Armistice Capital, LLC transactions in Rockwell Medical, Inc. stock. As of the latest transaction made, Armistice Capital, LLC holds 3,221,640 shares of RMTI stock, worth $13.2 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
3,221,640
Previous 2,629,640 22.51%
Holding current value
$13.2 Million
Previous $4.37 Million 29.9%
% of portfolio
0.07%
Previous 0.06%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$1.45 - $1.92 $858,400 - $1.14 Million
592,000 Added 22.51%
3,221,640 $5.67 Million
Q1 2024

May 15, 2024

BUY
$1.23 - $1.86 $956,497 - $1.45 Million
777,640 Added 41.99%
2,629,640 $4.37 Million
Q4 2023

Feb 13, 2024

SELL
$1.58 - $2.44 $1.52 Million - $2.35 Million
-965,000 Reduced 34.26%
1,852,000 $3.5 Million
Q3 2023

Nov 14, 2023

BUY
$1.83 - $6.19 $4.45 Million - $15.1 Million
2,432,000 Added 631.69%
2,817,000 $5.86 Million
Q2 2023

Aug 14, 2023

BUY
$1.8 - $5.46 $37,800 - $114,660
21,000 Added 5.77%
385,000 $2.1 Million
Q1 2023

May 15, 2023

SELL
$1.03 - $2.62 $871,458 - $2.22 Million
-846,076 Reduced 69.92%
364,000 $658,000
Q4 2022

Feb 14, 2023

BUY
$0.84 - $1.39 $210,903 - $348,995
251,076 Added 26.18%
1,210,076 $1.22 Million
Q3 2022

Nov 14, 2022

BUY
$1.2 - $2.11 $902,988 - $1.59 Million
752,490 Added 364.38%
959,000 $1.27 Million
Q2 2022

Aug 15, 2022

BUY
$1.28 - $4.84 $264,332 - $999,508
206,510 New
206,510 $266,000

Others Institutions Holding RMTI

About ROCKWELL MEDICAL, INC.


  • Ticker RMTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 10,675,200
  • Market Cap $43.8M
  • Description
  • Rockwell Medical, Inc., together with its subsidiaries, operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally. The company offers Triferic Dialysate and Triferic AVNU, an iro...
More about RMTI
Track This Portfolio

Track Armistice Capital, LLC Portfolio

Follow Armistice Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Armistice Capital, LLC with notifications on news.